CBE, CNSI, CSEP, GSDS, OFFICE OF DEVELOPMENT-PARENT FUND, AND WISE PRESENT A CAREER TALK PRESENTS A SEMINAR: Kristztina M. Zsebo, Ph.D., President Biovest Consulting, LLC.
Current Topics in Bioengineering Career Talk
Thursday, October 6, 2016
2:00– 3:00 pm
*Light refreshments will be provided*
Krisztina M. Zsebo, Ph.D.
President, Biovest Consulting, LLC
Career Talk: From the Bench to the Board Room, A Career in Biotechnology
Dr. Zsebo is a biopharmaceutical veteran with 32 years of experience, and numerous successful ventures, in the Biotechnology industry. Most recently, she was CEO & President of Celladon Corporation, where she took the company public and led a team of researchers who took a basic research project through to Phase 2b clinical trials. She has been an Entrepreneur in Residence at Enterprise Partners Venture Capital, CEO & President of Remedyne Corporation, and Executive VP of Connetics Corporation. When heading up the Biopharmaceutical and Implant Division of ALZA Corporation, she oversaw the development and filing of the NDA for Viadur®, an implantable drug/device for prostate cancer patients. And when she was Executive VP of Research and Product Development at Cell Genesys, she filed their first IND for a gene therapy product for AIDS, and managed the division that spun off to become Abgenix, one of the most successful biotech companies. Kris began her career with eight years at Amgen in research and product development where she worked on the discovery of NEUPOGEN®, Stem Cell Factor, and various aspects of EPOGEN® development. Dr. Zsebo holds a B.S. in Biochemistry (University of Maryland), a M.S. in Biochemistry and Biophysics (Oregon State University) and a PhD in Comparative Biochemistry and Molecular Biology (UC Berkeley). She has published over 100 articles on biotechnology and holds 21 patents in the biotech field. In this talk, Kris will share several case studies of product candidates (biologics) as they evolved within the industry along with important lessons learned regarding transitioning from academia to industry.